Scientists test One-Shot cancer drug combo in Early-Stage trial
NCT ID NCT06824363
Summary
This is a very early, small study to see if a single dose of two immunotherapy drugs can change the immune cells inside certain stomach and esophageal tumors. It will involve 34 adults with early-stage cancer who have a specific genetic change (ARID1A mutation) and have not had any prior treatment. The main goal is to learn how the drugs affect the tumor's environment and to check if the study procedures are safe and feasible for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Chao Family Comprehensive Cancer Center, University of California, Irvine
Orange, California, 92868, United States
Conditions
Explore the condition pages connected to this study.